Detalles de la búsqueda
1.
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.
Circulation
; 133(13): 1230-9, 2016 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26896437
2.
Isolation and characterization of the circulating truncated form of PCSK9.
J Lipid Res
; 55(7): 1505-14, 2014 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24776539
3.
Circulating PCSK9 is a strong determinant of plasma triacylglycerols and total cholesterol in homozygous carriers of apolipoprotein ε2.
Clin Sci (Lond)
; 126(9): 679-84, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24308640
4.
Common and low-frequency genetic variants in the PCSK9 locus influence circulating PCSK9 levels.
Arterioscler Thromb Vasc Biol
; 32(6): 1526-34, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22460556
5.
Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.
J Clin Lab Anal
; 27(6): 504-10, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24218134
6.
Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration.
Clin Chem
; 58(8): 1225-32, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22679180
7.
Determination of cathepsin S abundance and activity in human plasma and implications for clinical investigation.
Anal Biochem
; 430(2): 130-7, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22922382
8.
Dual-monoclonal, sandwich immunoassay specific for glucose-dependent insulinotropic peptide1-42, the active form of the incretin hormone.
Clin Chem
; 57(6): 849-55, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21515744
9.
Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidaemia.
Clin Sci (Lond)
; 121(9): 397-403, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21539517
10.
Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans.
Arterioscler Thromb Vasc Biol
; 30(12): 2666-72, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20884874
11.
Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents.
Lipids Health Dis
; 10: 38, 2011 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21352602
12.
Fenofibrate treatment increases human serum proprotein convertase subtilisin kexin type 9 levels.
J Lipid Res
; 51(2): 345-51, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19738285
13.
High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol.
J Lipid Res
; 51(9): 2714-21, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20525997
14.
Healthy individuals carrying the PCSK9 p.R46L variant and familial hypercholesterolemia patients carrying PCSK9 p.D374Y exhibit lower plasma concentrations of PCSK9.
Clin Chem
; 55(12): 2153-61, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19797716
15.
A dual-monoclonal, sandwich immunoassay specific for glucagon like peptide-19-36/7 (GLP-19-36/7).
Clin Biochem
; 49(12): 897-902, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27208557
16.
Affinity capture elution bridging assay: A novel immunoassay format for detection of anti-therapeutic protein antibodies.
J Immunol Methods
; 431: 45-51, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26874304
17.
An innovative and highly drug-tolerant approach for detecting neutralizing antibodies directed to therapeutic antibodies.
Bioanalysis
; 8(20): 2157-68, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27593891
18.
PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the day.
Lipids
; 49(5): 445-55, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24659111
19.
Novel sandwich immunoassays for the measurement of total and active FGF21.
Bioanalysis
; 6(24): 3283-93, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25534786
20.
Serum hepcidin levels are associated with obesity but not liver disease.
Obesity (Silver Spring)
; 22(3): 836-41, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23512600